Healthcare >> CEO Interviews >> March 15, 2019

Interview with the Director, President and CEO: Protagonist Therapeutics, Inc. (NASDAQ:PTGX)

Patel, Dinesh
Dr. Dinesh Patel has been on the board of directors and the President and Chief Executive Officer of Protagonist Therapeutics, Inc. since December 2008. He has 35 years of executive, entrepreneurial and scientific experience that span the pharmaceutical, biotechnology and biopharmaceutical industries. Earlier, he was the Chief Executive Officer and Co-Founder of Miikana Therapeutics, an oncology company. Prior to Miikana, he was a Co-Founder of Versicor, which was acquired by Pfizer in 2005 for $1.9 billion. Prior to that, he worked at Affymax and started his industrial career at Bristol-Myers Squibb in 1985. He received a doctorate in chemistry from Rutgers University and a B.S. degree in industrial chemistry from S. P. University, Vallabh Vidyanagar, India. Profile
Word count: 2,554

TWST: What is Protagonist Therapeutics?

Dr. Patel: First and foremost, we are a drug company that is focused exclusively on peptide